List view / Grid view
6 January 2011 | By College Hill Ltd
Bicycle Therapeutics today announced the appointment of Andy Sandham as non-executive Chairman. Andy brings over 30 years experience in building biotechnology businesses...
5 January 2011 | By The Scott Partnership
Increasing trial complexity and duration of studies, patient non-compliance is a growing issue...
5 January 2011 | By Citigate Dewe Rogerson Ltd
Crescendo Biologics Limited (Crescendo) today announces the appointment of Mike Romanos as Chief Executive Officer...
5 January 2011 | By Smith & Smith PR
Unlicensed medicines manufacturer Quantum Pharmaceutical has appointed Pauline Carter as its new National Account Manager...
5 January 2011 | By The Scott Partnership
Landmark study transforms the previous scientific understanding of immunity to viral diseases like the common cold, 'winter vomiting' and gastroenteritis...
5 January 2011 | By The Scott Partnership
ERT's eC-SSRS solution facilitates compliance with FDA guidance on suicidality assessment in clinical trials...
5 January 2011 | By Citigate Dewe Rogerson
arGEN-X BV, announced it has entered into an alliance with Lilly to discover and develop novel therapeutic antibody products against targets submitted by Lilly...
4 January 2011 | By The Scott Partnership
Exco InTouch, announces the appointment of Judith Teall. The newly created position will drive Exco InTouch to build on its “patient centric” approach to managing clinical trials...
4 January 2011 | By GlaxoSmithKline
Targeted oral treatment slows down the progression of advanced kidney cancer...
3 January 2011 | By AstraZeneca
AstraZeneca has notified Abbott that it will discontinue the development of CERTRIAD on 22 January 2011...
21 December 2010 | By The Scott Partnership
ERT, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is December 21, 2010...
20 December 2010 | By The Scott Partnership
PharmaNet, are available to offer guidance on the regulatory pathway for biosimilar development...
20 December 2010 | By M:Communications
Proximagen, has signed an exclusive agreement with GSK to acquire the global rights to two drug development programmes...
16 December 2010 | By The Scott Partnership
The Scott Partnership, has been selected by the organisers of Pittcon 2011 to deliver a short-course entitled ‘Marketing in Asia Pacific...
16 December 2010 | By The Scott Partnership
ERT, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions...
